C57BL/6JCya-Cntn3em1/Cya
Common Name:
Cntn3-KO
Product ID:
S-KO-03555
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cntn3-KO
Strain ID
KOCMP-18488-Cntn3-B6J-VA
Gene Name
Product ID
S-KO-03555
Gene Alias
Pang
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
6
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cntn3em1/Cya mice (Catalog S-KO-03555) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000032159
NCBI RefSeq
NM_008779
Target Region
Exon 2
Size of Effective Region
~1.9 kb
Detailed Document
Overview of Gene Research
Cntn3, a member of the contactin family, is primarily expressed in the nervous system. It plays roles in neural development, likely through its interactions with other proteins. For example, it binds to the Amyloid Precursor Protein (APP), with the second Fibronectin domain (Fn(2)) in Cntn3 and the copper binding domain (CuBD) in APP mediating this interaction [1]. It may also be involved in the receptor tyrosine-protein kinase (ErbB) signalling pathway [2].
In a study on glioblastoma multiforme (GBM), Cntn3 was significantly downregulated, and patients with lower Cntn3 expression had a shorter overall survival time, indicating it could be an independent prognostic indicator for GBM [2]. In tuberous sclerosis complex, Cntn3 expression was lower in cortical tubers during the early postnatal period compared to controls, which may contribute to neuropsychiatric co-morbidities [4]. Also, in a proteomics Mendelian randomization study, the CNTN3/NCSS1 protein level ratio was associated with type 2 diabetes [3].
In conclusion, Cntn3 is important in neural development and its dysregulation is associated with diseases like GBM, tuberous sclerosis complex-related neuropsychiatric co-morbidities, and potentially type 2 diabetes. Understanding Cntn3's function in these contexts may provide insights into disease mechanisms and potential therapeutic targets.
References:
1. Peng, Xi, Williams, John, Smallwood, Philip M, Nathans, Jeremy. 2019. Defining the binding interface of Amyloid Precursor Protein (APP) and Contactin3 (CNTN3) by site-directed mutagenesis. In PloS one, 14, e0219384. doi:10.1371/journal.pone.0219384. https://pubmed.ncbi.nlm.nih.gov/31318883/
2. Zhu, Yi-Fang, Guo, Yuan-Biao, Zhang, Han-Yu, Pan, Bi-Ran, Liu, Lei. 2019. Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme. In Oncology letters, 18, 1863-1871. doi:10.3892/ol.2019.10482. https://pubmed.ncbi.nlm.nih.gov/31423255/
3. Zhang, Yue-Yang, Chen, Bing-Xue, Yang, Qin, Wan, Qin. 2024. The causal relationship between plasma protein-to-protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study. In Diabetes, obesity & metabolism, 26, 4410-4417. doi:10.1111/dom.15792. https://pubmed.ncbi.nlm.nih.gov/39021342/
4. Korotkov, Anatoly, Luinenburg, Mark J, Romagnolo, Alessia, Mills, James D, Aronica, Eleonora. 2022. Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period. In Journal of neurodevelopmental disorders, 14, 8. doi:10.1186/s11689-022-09416-2. https://pubmed.ncbi.nlm.nih.gov/35030990/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen